(E)-3-(2,3-DICHLORO-4-(4-FLUOROPHENYLTHIO)PHENYL)ACRYLIC ACID, 95.0%, 250mg

5-Aminomethylfuroic acid, 95.0%, 250mg

4,4-Bipiperidine, 95.0%, 5g

1-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethan-1-ol, 97%, 250mg

6-Bromospiro[chromane-2,1'-cyclohexan]-4-one, 97%, 5g

Bortezomib>98.0%(HPLC)10mg

3,5-Dithiocyanatopyridine-2,6-diamine, 95.0%, 1mg

1,3-Dimethyl-1H-pyrazol-5-ol, 95.0%, 1g

1-(4-(Aminomethyl)phenyl)-N-methylmethanamine, 95%, 500mg

(5-Methyl-2-oxo-benzooxazol-3-yl)-acetic acid, 95.0%, 1g

Boc-Cys(Fm)-OH, 95.0%, 5g

2-(2,6-Dioxopiperidin-3-yl)-5-(prop-2-yn-1-yloxy)isoindoline-1,3-dione, 98%, 50mg

N-(1',2-Dihydroxy-[1,2'-binaphthalen]-4'-yl)-4-methoxybenzenesulfonamide, 98%, 100mg